resources

Speciality Medicines Ltd.

BSE: 544738

SME

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

144.00-5.0 (-3.36%)

23 Oct, 1:59 PM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Speciality Medicines Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2026
Annual Reports	FY 2026
Quarterly Results	Mar
Conference Calls	—
Presentations	—

Corporate Announcements and Regulatory Filings

Speciality Medicines Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201815 Oct 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We Hereby Submit the Compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018.
Closure of Trading Window28 Sept 2026
Closure of Trading Window
We hereby submit intimation regarding closure of trading Window for the Half year ended on September, 30 2026.
AGM28 Sept 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
We hereby submit Voting Results and Consolidated Scrutinizer report of the 5th AGM of the Company.
AGM28 Sept 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
We hereby submit Proceedings of 5th AGM of the Company.
Newspaper Publication5 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
We hereby submit Newspaper publication of Notice of 5th Annual general meeting of the company.
Reg. 34 (1) Annual Report3 Sept 2026
Reg. 34 (1) Annual Report.
We hereby Submit Annual Report of FY 2025-26.
EGM3 Sept 2026
Notice Of 5Th Annual General Meeting
We hereby submit Notice of 5th AGM to be held on September 28, 2026.
Outcome without intimation3 Sept 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On September 03, 2026
We hereby submit Outcome of the board meeting held on September 03, 2026
General12 Aug 2026
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 Regarding Approval For Two New Products In Ethiopia
We hereby submit intimation regarding approval for Two new products in Ethiopia.
Press Release / Media Release12 Aug 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
We hereby submit Press Release titled "Speciality Medicines Limited Secures Regulatory Approval for Two New Products in Ethiopia".
General4 Aug 2026
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 Regarding Appointment Of Investor And Public Relations Agency Of The Company
We hereby submit the Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding Appointment of Investor and Public Relations agency of the Company.
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP)Regulation, 2018
Outcome of Board Meeting28 May 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E On May 28, 2026
We hereby submit the Outcome of Board Meeting held On May 28, 2026.
Board Meeting21 May 2026
Board Meeting Intimation for Meeting Of Board Of Directors Of Speciality Medicines Limited To Be Held On May 28, 2026
Speciality Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve 1. Audited Standalone ....
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201119 May 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Niraj Shah
General28 Apr 2026
Intimation Of Contact Details Of Key Managerial Personnel Pursuant To Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
We hereby submit the intimation of Contact details of KMP pursuant to Regulation 30(5) of SEBI(LODR) Regulations, 2025.
Change in Management28 Apr 2026
Announcement under Regulation 30 (LODR)-Change in Management
We hereby inform that the board in its meeting held on April 28, 2026 has approved (1) Appointment of M/s. Hardik Jetani & Associates as secretarial Auditor of the Company for the Financial ....
Outcome without intimation28 Apr 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On April 28, 2026
We hereby submit the Outcome of Board Meeting held on today i.e. April 28, 2026.
Award of Order / Receipt of Order23 Apr 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
We hereby submit the Corporate announcement on order booking.
Award of Order / Receipt of Order22 Apr 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
We hereby submit the Corporate annoucement on order booking.

Frequently Asked Questions

Where can I download the annual report of Speciality Medicines Ltd.?

Annual reports of Speciality Medicines Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Speciality Medicines Ltd.?

Quarterly earnings results and presentations of Speciality Medicines Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Speciality Medicines Ltd. publish earnings call transcripts?

Earnings call transcripts of Speciality Medicines Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Speciality Medicines Ltd.?

Investor presentations and annual day presentations of Speciality Medicines Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Speciality Medicines Ltd.?

Corporate announcements and regulatory filings of Speciality Medicines Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Speciality Medicines Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Speciality Medicines Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Speciality Medicines Ltd.?

The ISIN (International Securities Identification Number) of Speciality Medicines Ltd. is INE0R0M01014. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Speciality Medicines Ltd. listed?

Speciality Medicines Ltd. is listed on NSE and BSE. The NSE symbol is 544738-BOM and the BSE code is -.

Where can I find the shareholding pattern of Speciality Medicines Ltd.?

The quarterly shareholding pattern of Speciality Medicines Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Speciality Medicines Ltd. on Sharpely?

Share price data for Speciality Medicines Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.